Abstract
Polycythemia vera (PV) and essential thrombocythemia (ET) can present in pediatric age as sporadic or familial diseases. To define the biologic profile of childhood PV and ET, we evaluated specific markers in a cohort of pediatric patients affected by PV and ET, including cases with familial occurrence.
| Original language | English |
|---|---|
| Pages (from-to) | 1048-1053 |
| Number of pages | 6 |
| Journal | Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
| Volume | 25 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published - 2007 |
Keywords
- 80 and over
- Adolescent
- Adult
- Aged
- Androgen
- Biological Markers
- Cell Surface
- Child
- Cohort Studies
- Erythroid Precursor Cells
- Erythropoietin
- Essential
- Female
- Follow-Up Studies
- GPI-Linked Proteins
- Humans
- Incidence
- Isoantigens
- Janus Kinase 2
- Male
- Membrane Glycoproteins
- Messenger
- Middle Aged
- Mutation
- Myeloproliferative Disorders
- Pedigree
- Polycythemia Vera
- RNA
- Receptors
- Rome
- Thrombocythemia
- Thrombopoietin
- Thrombosis
- Time Factors
Fingerprint
Dive into the research topics of 'Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver